![Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots | Fierce Pharma Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1617974455/jnjleiden.jpg/jnjleiden.jpg?VersionId=QDsYRtAuBklf06X0c9ocvuJAw.bYNkpX)
Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots | Fierce Pharma
![EMA flags Johnson & Johnson COVID vaccine for rare disorder, passes mRNA shots for one side effect but probes another | Fierce Pharma EMA flags Johnson & Johnson COVID vaccine for rare disorder, passes mRNA shots for one side effect but probes another | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1636640244/JNJIOffice3.jpg/JNJIOffice3.jpg?VersionId=sPiBblDJUelQ0k5fRKykK5qIrtOuDNhJ)
EMA flags Johnson & Johnson COVID vaccine for rare disorder, passes mRNA shots for one side effect but probes another | Fierce Pharma
![Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study | The BMJ Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study | The BMJ](https://www.bmj.com/content/bmj/371/bmj.m3434/F2.medium.jpg)
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study | The BMJ
EU regulator backs Johnson & Johnson's COVID-19 vaccine despite finding possible link to rare blood clots - The Globe and Mail
![Concerns over rare clotting disorders halt use of Johnson & Johnson's COVID-19 vaccine | Science | AAAS Concerns over rare clotting disorders halt use of Johnson & Johnson's COVID-19 vaccine | Science | AAAS](https://www.science.org/do/10.1126/science.abi9935/abs/J%26J_vaccine_1280x720.jpg)